Over decades, researchers have found that THC may help treat pain, nausea, loss of appetite and other problems, while CBD was thought to be biologically inactive in humans. But in the past 10 years, scientists have concluded that CBD may be quite useful. Dozens of studies have found evidence that the compound can treat epilepsy as well as a range of other illnesses, including anxiety, schizophrenia, heart disease and cancer.
The U.S. Department of Health & Human Services also recommends that consumers should be aware of any active ingredients that dietary supplements may contain. An active ingredient of a substance is any component that produces a biological or chemical effect on the body. Our products do contain active ingredients. The most abundant active ingredient in our supplements is the CBD in our hemp extract.
In the past few years, just such a cure has seemingly presented itself. Amid the less common remedies that can be found on the internet—special diets, meditation, biofeedback, surgical implants—a new product has recently gained prominence: CBD oil (sometimes known simply as “hemp oil”), so named for its chief chemical compound, cannabidiol, which occurs naturally in cannabis plants. In online forums and news articles, CBD has been hailed as a new frontier in epilepsy treatment, with parents testifying that it managed to stop their children’s seizures when nothing else could.
Of course, the easiest solution, advocates say, is for the federal government to legalize cannabis completely. If cannabis were legalized—the whole plant and all its extracts, no confusing singling-out of specific compounds or anatomical features—then U.S. drug companies would be able to carefully cultivate and research its medicinal properties, and submit their findings to regulatory bodies like the FDA for trials and approval.
I used to be into the vaping community a bit more but didn’t really see the benefit once the excitement of vaping wore off. Where’s the benefit?! Well once I found Hemp Bombs and the joy of CBD in general I discovered that vaping can once again be great and exciting and with a much needed benefit added to the mixture. I find vaping beneficial and worth doing now that CBD vapes are in the market.
Let’s start by looking at THC. THC (tetrahydrocannabinol) is the compound found in cannabis with psychotropic properties. Medical marijuana companies breed their plants to have the highest concentrations of this compound. It is associated with the feeling of being high that marijuana smokers experience. Effects include feelings of euphoria, pain relief and sometimes increased anxiety and paranoia.
Research suggests that CBD may exert some of its pharmacological action through its inhibition of fatty acid amide hydrolase (FAAH), which may in turn increase the levels of endocannabinoids, such as anandamide, produced by the body. It has also been speculated that some of the metabolites of CBD have pharmacological effects that contribute to the biological activity of CBD.
It depends on your pet and the medicine being used. There have been many examples of dogs being more receptive to PurCBD than traditional medications, especially with anti-seizure, anti-inflammatory, and anti-anxiety medications. Always check with your veterinarian before starting, stopping, or adjusting the dosage of any prescription medication. Many drugs, especially anti-seizure medications, must be weaned off slowly or else deadly withdrawal symptoms can occur.
CBD primarily interacts with the body’s endocannabinoid system, a grouping of millions of cannabinoid receptors found throughout your body, but are primarily clustered in the brain and central nervous system. While CBD is a phytocannabinoid, or plant-based cannabinoid, your body also naturally produces cannabinoids, known as endocannabinoids. Almost every organ of your body, including your skin and digestive tract, contains cannabinoid receptors. The endocannabinoid system has four primary purposes including neuroprotection, stress relief, immune response, and regulating the body’s general state of balance, impacting faculties such as appetite, sleep, mood, and pain.
Some individuals have been found to have mutations on the CNR1 gene, which is responsible for coding the CB1 receptor (a type of receptor in cells throughout your body that interacts with cannabinoids). Issues with the CNR1 gene can ultimately result in a poorly functioning endocannabinoid system, which is an important variable when figuring out how to use CBD oil.
Green Roads World pet CBD product utilizes high omega-3 krill and hemp oils. Omega-3s are an important element in the diets companion pets. Essential oils have been shown to have a positive correlation to animal health. Our CBD oil for dogs come in three concentrations: Regular Strength, Pro Strength and, Extra Strength. These 30ml bottles contain 75mg, 150mg, or 300mg of CBD respectively. Just like humans, animals will respond differently to varying doses of CBD. Customers are urged to make a dosage selection appropriate to the size of their pet. A pet CBD oil could be the perfect solution to your companion needs. Feel free to contact our friendly customer service team if you have any questions remaining.
Some manufacturers ship CBD products nationally, an illegal action which the FDA has not enforced in 2018, with CBD remaining as the subject of an FDA investigational new drug evaluation and is not considered legal as a dietary supplement or food ingredient as of November 2018. CBD is openly sold in head shops and health food stores in some states where such sales have not been explicitly legalized.
Disclaimer: These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Information contained or made available through the Canna-Pet® website is not intended to constitute or substitute for legal advice or veterinary advice. Read our policy on blogs and reviews.
^ Jump up to: a b Devinsky, Orrin; Cilio, Maria Roberta; Cross, Helen; Fernandez-Ruiz, Javier; French, Jacqueline; Hill, Charlotte; Katz, Russell; Di Marzo, Vincenzo; Jutras-Aswad, Didier; Notcutt, William George; Martinez-Orgado, Jose; Robson, Philip J.; Rohrback, Brian G.; Thiele, Elizabeth; Whalley, Benjamin; Friedman, Daniel (22 May 2014). "Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders". Epilepsia. 55 (6): 791–802. doi:10.1111/epi.12631. PMC 4707667. PMID 24854329.